CE35 - Santé-Environnement : Environnement, pathogènes et maladies infectieuses émergentes et réémergentes, résistance aux antimicrobiens

ECOLOGY AND EVOLUTION OF TRANSMISSIBLE CANCERS – TRANSCAN

Submission summary

One of the most enigmatic host-pathogen system concerns directly transmissible cancers, in which the pathogen is a clonal infectious malignant cell line. By an integration of molecular, ecological and evolutionary approaches, including modelling, the project TRANSCAN proposes to decipher the biology of 2 emblematic transmissible cancers: the Tasmanian devil (Sarcophilus harrisii) and their two facial tumors and the recently discovered horizontally transmitted leukemia in mussels (Mytilus spp). TRANSCAN is organized around 4 questions: 1) why do transmissible cancers emerge ? 2) How do they evolve? 3) what are their ecological and evolution impacts ? and 4) How to manage them ? Not only TRANSCAN will provide novel and unprecedented information on the biology of transmissible cancers it will also provide a conceptual and theoretical framework that explain and predict the evolution of transmissible cancers, and how to prevent victim wildlife populations from potential extinction.

Project coordination

Frédéric THOMAS (Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

ISEM Institut des Sciences de l'Evolution de Montpellier
IHPE Interactions Hôtes-Pathogènes-Environnements
IRD INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT - IRD DELEGATION ILE DE France
MIVEGEC Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle

Help of the ANR 526,132 euros
Beginning and duration of the scientific project: October 2018 - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter